Auren Rx Review: Two Rungs on Every SKU, and Which One We File

Auren Rx (aurenrx.com) does something we wish more programs did: every product carries two explicit prices, a discounted subscription rate and a labeled "monthly, no commitment" rate, side by side on the page.¹ You do not have to guess which one you are being quoted. That structure makes it one of the cleanest ladders on this bench — and it also makes it easy to file the wrong number, in two separate ways.

The two rungs, and the one we file

Standard semaglutide is $169 a month subscribed and $199 month-to-month. Standard tirzepatide is $259 subscribed and $299 month-to-month. Auren Rx also runs a separately priced microdose program: semaglutide at $129 subscribed and $149 monthly, tirzepatide at $229 and $250.

Over twelve months that is $2,388 against $2,028 for standard semaglutide, and $3,588 against $3,108 for tirzepatide. The subscription discount is $30 to $40 a month depending on the product — real money, and unusually, it buys you nothing you have to commit to for longer than one billing cycle either way.

We file $199 and $299, because those are the rungs a reader can pay without agreeing to anything. That is the standing rule behind every figure on this site, and the reasoning is in the true monthly cost of a GLP-1.

Two ways to capture Auren Rx wrongly

The first trap is on the page itself. The weight-loss product selector ships with tirzepatide preselected. Open the page, read the big number, and you have recorded $259 or $299 as "the price" of a program you thought was semaglutide. This is the classic shifted-column error, and it is live on a real site rather than hypothetical.

The second is machine-readable. Auren Rx's own Product structured data emits the subscribe price as the offer price — $169 and $259. Anything that ingests its schema instead of reading its page records the lower rung and never sees the monthly one. If you find Auren Rx quoted at $169 somewhere, that is almost certainly where the number came from.

The site's navigation carries a third version. It advertises semaglutide and tirzepatide "from $129 a month", which is the microdose subscribe rung sitting under a general GLP-1 heading. It is a real, purchasable price for a real product, but the cheapest standard GLP-1 rung is $70 a month above it. Microdosing is a different treatment with a different evidence base, not a discount on the standard one — see what the evidence actually says about GLP-1 microdosing before you treat the two as interchangeable.

The rest of the ladder

Auren Rx publishes both rungs for every product it sells, which makes it the most granular non-GLP-1 price list in this cohort. NAD+ runs across seven rungs and three routes — injection at $209 month-to-month, nasal sprays from $169 to $249 depending on strength and volume, and creams at $155 and $215. Sermorelin is $199, glutathione $119 by injection and $109 nasal, GHK-Cu cream $109, tretinoin $49, oral minoxidil $49, valacyclovir $39 and $49, and estradiol from $69 to $99 across patches and tablets.

There is no prepay tier anywhere in the catalogue, so there is no prepay rung that can be mistaken for a monthly one — the single most common source of a wrong cheap figure. There is also no research-chemical line: no retatrutide, no melanotan, no testosterone, which distinguishes it from several others we tested this month.

Billing cadence, disclosed

Auren Rx bills approximately every 28 to 30 days, and says so. That matters arithmetically. Twelve 30-day cycles is a calendar year; thirteen 28-day cycles is also a year. At the short end of that window a $199 plan could bill thirteen times, which is $2,587 rather than $2,388 — so budget on the cycle, not on the calendar.

The important part is that Auren Rx tells you the cadence. Vyvron bills every four weeks and prints "/mo", which is the same arithmetic with the disclosure removed.

Who is behind the prescription, and where you can use it

The medical group is Beluga Health, P.A., an established telehealth professional association, and the operating entity is Hades Capital LLC. No individual prescriber is named and no NPI is published, so nothing here can be checked against the national provider registry.

The dispensing pharmacy is never named individually — it is described as Auren Rx or a partner within its own pharmacy network. You may also elect to use a local pharmacy of your choice, in which case the membership fee covers the clinical service and you pay for the medication separately. That is a genuinely useful option and a materially different cost structure, and it is worth asking about before you assume the $199 is all-in.

The largest gap in an otherwise good disclosure record is geographic: Auren Rx never publishes the states it serves. Its terms say services are available in certain states and leave it there. Every other program on this bench either lists its states or claims all 50; this one does neither, so you will not know whether it can prescribe to you until you have started an intake. That is check two on our provider checklist, and it is unanswerable from the outside here.

The membership fee is charged on the day membership commences and is non-refundable once paid. Membership begins after a provider communicates a care plan and you elect to proceed, so it follows clinical review rather than preceding it — better than the several programs here that charge at intake. Cancellation is month-to-month by email or in-account, with no refund of fees already paid, and the account can be paused with no further charges until you order a refill.

The regulatory screen was clean: the trading name, the legal entity and the medical group each returned zero company-column matches in the FDA's live warning-letter index in August 2026, in a pass whose positive control correctly returned a known 2026 letter for an unrelated seller.²

Where it lands on value

Auren Rx is not the cheapest program on this bench — Pepti and Trellis Vitality both sit below it — but it is the one whose price structure is hardest to misread once you know where the two traps are. Two labeled rungs on every SKU, no prepay tier, a disclosed billing cadence and a real option to source medication elsewhere is a lot of structure to check against.

Against that: no NPI, no named pharmacy, and no published state list. Put it up on the cheapest semaglutide board and the cheapest tirzepatide board, price your own year with the cost calculator, and read the sourced background in our research library.